A collaboration between Huntington’s disease families, clinicians, and researchers to accelerate progress toward effective treatments.
Postcard from Palm Springs
Your information is powerful! Learn about current research opportunities.
Clinical research platform
Enroll-HD is a clinical research platform and the world’s largest observational study for Huntington’s disease families. It is a resource for the entire HD community, including families, clinicians, researchers, advocates, and anyone else who has a connection to or an interest in HD.
A platform for the whole HD community.
Clinical Sites Worldwide
Enroll-HD: Jan 1, 2023 data cut
Contact us for trial support
Send us a message. An Enroll-HD team member will get back to you as soon as possible.
Roche Phase II GENERATION HD2 study underway
Roche released a community letter...
New Enroll-HD periodic dataset (PDS6) now available!
New Enroll-HD periodic dataset (PDS6)...
Disappointing news from Novartis about branaplam and the VIBRANT-HD trial
The pharmaceutical company Novartis has...
uniQure gets the green light to resume testing HD gene therapy
In August 2022, uniQure announced...
European Medicines Agency issues qualification opinion that Enroll-HD can provide data and infrastructure support for post-authorization monitoring of medical products for Huntington’s disease
European Medicines Agency issues qualification opinion that Enroll-HD can provide...